{
    "nct_id": "NCT03919669",
    "title": "Longitudinal Evaluation of [18-F]MK-6240 as a Novel Tau PET Radiotracer in Patients With Alzheimer's Disease Dementia or Mild Cognitive Impairment Compared to Healthy Volunteers",
    "status": "COMPLETED",
    "last_update_time": "2023-08-02",
    "description_brief": "This is a longitudinal, observational study evaluating the imaging characteristics of the tau PET radioligand \\[18F\\]MK-6240 in Alzheimer's disease (AD), Mild Cognitive Impairment (MCI) and Healthy Volunteer (HV) subjects. Up to 42 subjects, including approximately 28 MCI/mild AD subjects, up to 5 moderate AD subjects, and 9 similarly aged HV subjects will be consented and screened. Imaging procedures include \\[11C\\]PiB to evaluate amyloid deposition, \\[18F\\]MK-6240 PET, and structural MRI. All subjects complete an evaluable baseline \\[18F\\]MK-6240 PET scan, as well as scans at 6, 12 and 24 months post-baseline. If unable to complete the 6 month, 12 month, or 24 month visit, an 18 month and/or 30 month visit may instead be scheduled, totaling a maximum of four time points.",
    "description_detailed": "N/A",
    "phase": [
        "PHASE2"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "DIAGNOSTIC",
    "results": {
        "participantFlowModule": {
            "groups": [
                {
                    "id": "FG000",
                    "title": "Healthy Volunteers",
                    "description": "As described in the study eligibility criteria:\n\n* Normal Cognition based on cognitive results at screening.\n* Healthy with no clinically relevant finding on physical examination at screening and upon reporting for the Baseline \\[18F\\]MK-6240 imaging visit.\n* CDR global score =0"
                },
                {
                    "id": "FG001",
                    "title": "Mild Cognitive Impairment",
                    "description": "As described in the study eligibility criteria:\n\n* Have screening \\[11C\\]PiB PET imaging demonstrating amyloid binding based on qualitative read or DVR index value \\>1.20.\n* MMSE score 26-30 (inclusive), CDR global score 0.5 for subjects with MCI\n* MMSE score 22-26 (inclusive), CDR global score 0.5 or 1 for subjects with mild dementia due to AD\n* MMSE score 16-21 (inclusive), CDR global score 1-2 for subjects with moderate dementia due to AD\n* A structural brain MRI with no evidence of non-AD disease to account for dementia or MRI exclusion criteria."
                },
                {
                    "id": "FG002",
                    "title": "Dementia",
                    "description": "As described in the study eligibility criteria:\n\n* Have screening \\[11C\\]PiB PET imaging demonstrating amyloid binding based on qualitative read or DVR index value \\>1.20.\n* MMSE score 26-30 (inclusive), CDR global score 0.5 for subjects with MCI\n* MMSE score 22-26 (inclusive), CDR global score 0.5 or 1 for subjects with mild dementia due to AD\n* MMSE score 16-21 (inclusive), CDR global score 1-2 for subjects with moderate dementia due to AD"
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "6"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "8"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "13"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "5"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "8"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "13"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Withdrawal by Subject",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "1"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG002",
                                    "numSubjects": "0"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "groups": [
                {
                    "id": "BG000",
                    "title": "Healthy Volunteers",
                    "description": "As described in the study eligibility criteria:\n\n* Normal Cognition based on cognitive results at screening.\n* Healthy with no clinically relevant finding on physical examination at screening and upon reporting for the Baseline \\[18F\\]MK-6240 imaging visit.\n* CDR global score =0"
                },
                {
                    "id": "BG001",
                    "title": "Mild Cognitive Impairment",
                    "description": "As described in the study eligibility criteria:\n\n* Have screening \\[11C\\]PiB PET imaging demonstrating amyloid binding based on qualitative read or DVR index value \\>1.20.\n* MMSE score 26-30 (inclusive), CDR global score 0.5 for subjects with MCI\n* MMSE score 22-26 (inclusive), CDR global score 0.5 or 1 for subjects with mild dementia due to AD\n* MMSE score 16-21 (inclusive), CDR global score 1-2 for subjects with moderate dementia due to AD\n* A structural brain MRI with no evidence of non-AD disease to account for dementia or MRI exclusion criteria."
                },
                {
                    "id": "BG002",
                    "title": "Dementia",
                    "description": "As described in the study eligibility criteria:\n\n* Have screening \\[11C\\]PiB PET imaging demonstrating amyloid binding based on qualitative read or DVR index value \\>1.20.\n* MMSE score 26-30 (inclusive), CDR global score 0.5 for subjects with MCI\n* MMSE score 22-26 (inclusive), CDR global score 0.5 or 1 for subjects with mild dementia due to AD\n* MMSE score 16-21 (inclusive), CDR global score 1-2 for subjects with moderate dementia due to AD"
                },
                {
                    "id": "BG003",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "6"
                        },
                        {
                            "groupId": "BG001",
                            "value": "8"
                        },
                        {
                            "groupId": "BG002",
                            "value": "13"
                        },
                        {
                            "groupId": "BG003",
                            "value": "27"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Categorical",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "<=18 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Between 18 and 65 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "1"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "2"
                                        }
                                    ]
                                },
                                {
                                    "title": ">=65 years",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "8"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "12"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "25"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "FULL_RANGE",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "69.85",
                                            "lowerLimit": "62",
                                            "upperLimit": "73"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "71.60",
                                            "lowerLimit": "67",
                                            "upperLimit": "78"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "74.52",
                                            "lowerLimit": "59",
                                            "upperLimit": "84"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "72.62",
                                            "lowerLimit": "59",
                                            "upperLimit": "84"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "8"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "13"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "3"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "5"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "14"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Ethnicity (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Not Hispanic or Latino",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "8"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "13"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "27"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Race (NIH/OMB)",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "American Indian or Alaska Native",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Asian",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Native Hawaiian or Other Pacific Islander",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Black or African American",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "White",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "8"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "13"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "27"
                                        }
                                    ]
                                },
                                {
                                    "title": "More than one race",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        }
                                    ]
                                },
                                {
                                    "title": "Unknown or Not Reported",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "0"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "0"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Region of Enrollment",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "classes": [
                        {
                            "title": "United States",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "8"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "13"
                                        },
                                        {
                                            "groupId": "BG003",
                                            "value": "27"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Change in [18F]MK-6240 Standard Uptake Value Ratio (SUVR) Uptake",
                    "description": "Composite mean SUVR across standard regions including: numerator was the entorhinal, amygdala, fusiform, inferior temporal, middle temporal cortex; denominator was the inferior cerebellum cortex. The SUVR is a ratio and has a theoretic interpretable minimum of 1.0. This primary outcome is reported by the three primary groups: Healthy Volunteers, Mild Cognitive Impairment, and Dementia.",
                    "populationDescription": "26 of the 27 participants completed the 12 month interval",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "SUVR",
                    "timeFrame": "Baseline to 12 months",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Healthy Volunteers",
                            "description": "As described in the study eligibility criteria:\n\n* Normal Cognition based on cognitive results at screening.\n* Healthy with no clinically relevant finding on physical examination at screening and upon reporting for the Baseline \\[18F\\]MK-6240 imaging visit.\n* CDR global score =0"
                        },
                        {
                            "id": "OG001",
                            "title": "Mild Cognitive Impairment",
                            "description": "As described in the study eligibility criteria:\n\n* Have screening \\[11C\\]PiB PET imaging demonstrating amyloid binding based on qualitative read or DVR index value \\>1.20.\n* MMSE score 26-30 (inclusive), CDR global score 0.5 for subjects with MCI\n* MMSE score 22-26 (inclusive), CDR global score 0.5 or 1 for subjects with mild dementia due to AD\n* MMSE score 16-21 (inclusive), CDR global score 1-2 for subjects with moderate dementia due to AD\n* A structural brain MRI with no evidence of non-AD disease to account for dementia or MRI exclusion criteria."
                        },
                        {
                            "id": "OG002",
                            "title": "Dementia",
                            "description": "As described in the study eligibility criteria:\n\n* Have screening \\[11C\\]PiB PET imaging demonstrating amyloid binding based on qualitative read or DVR index value \\>1.20.\n* MMSE score 26-30 (inclusive), CDR global score 0.5 for subjects with MCI\n* MMSE score 22-26 (inclusive), CDR global score 0.5 or 1 for subjects with mild dementia due to AD\n* MMSE score 16-21 (inclusive), CDR global score 1-2 for subjects with moderate dementia due to AD"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "6"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "8"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "13"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "0.00",
                                            "spread": "0.05"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.10",
                                            "spread": "0.07"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": "0.12",
                                            "spread": "0.16"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "The Correlation Between the Change in [18F]MK-6240 Uptake and the Change in the Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-cog) Using Items 1-11",
                    "description": "This outcome is correlational and therefore the arms/groups are collapsed to All Subjects so that we can assess the overall pattern of relationship between cognition and tau signal across the entire continuum of Alzheimer's disease. The ADAS-cog is one of the most frequently used tests to measure cognition in clinical trials in AD. The first 11 items of the ADAS-cog were used for this outcome. The ADAS was developed as a two-part scale: one that measured cognitive functions and one that measured non-cognitive functions such as mood and behavior. Most current research, including this study, uses the ADAS-Cog, which is the sub-scale that measures cognitive ability. The ADAS-cog score is based on incorrect items or errors and has a range of 0-50, where lower scores indicate better cognitive functioning.",
                    "populationDescription": "26 of the 27 participants completed the 12 month interval",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "Spearman Rho",
                    "timeFrame": "Baseline to 12 months",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "All Subjects",
                            "description": "All subjects will complete PET imaging sessions evaluating the tau PET radioligand \\[18F\\]MK-6240 at baseline, as well as at 6, 12 and 24 months post-baseline.\n\nIf unable to complete the 6 month, 12 month, or 24 month visit, an 18 month and/or 30 month visit may instead be scheduled, totaling a maximum of four time points.\n\nAll Subjects: All subjects will be given the experimental tau PET radioligand \\[18F\\]MK-6240"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "27"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": ".02"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Correlate the Changes in [18F]MK-6240 Uptake and Changes in Clinical Cognitive Assessments by Clinical Dementia Rating Scale (CDR).",
                    "description": "This outcome is correlational and therefore the arms/groups are collapsed to All Subjects so that we can assess the overall pattern of relationship between cognition and tau signal across the entire continuum of Alzheimer's disease. The CDR was developed primarily for use in persons with dementia of the Alzheimer type. The six domains of CDR are: Memory, Orientation, Judgment and Problem-solving, Community Affairs, Home and Hobbies, and Personal Care. Each domain is rated on a 5-point scale of functioning: 0 no impairment; 0.5 questionable impairment; 1 mild impairment; 2 moderate impairment; and 3 severe impairment. The Sum of Boxes is the score used which is simply the sum of the 6 Domain Box Scores. The range is 0-18 with lower scores indicating better cognitive function.",
                    "populationDescription": "26 of the 27 participants completed the 12 month interval",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "Spearman Rho",
                    "timeFrame": "Baseline to 12 months",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "All Subjects",
                            "description": "All subjects will complete PET imaging sessions evaluating the tau PET radioligand \\[18F\\]MK-6240 at baseline, as well as at 6, 12 and 24 months post-baseline.\n\nIf unable to complete the 6 month, 12 month, or 24 month visit, an 18 month and/or 30 month visit may instead be scheduled, totaling a maximum of four time points.\n\nAll Subjects: All subjects will be given the experimental tau PET radioligand \\[18F\\]MK-6240"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "27"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": ".23"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Correlate the Changes in [18F]MK-6240 Uptake and Changes in Clinical Cognitive Assessments by Mini-Mental Status Exam (MMSE)",
                    "description": "This outcome is correlational and therefore the arms/groups are collapsed to All Subjects so that we can assess the overall pattern of relationship between cognition and tau signal across the entire continuum of Alzheimer's disease. The MMSE is a sensitive, valid and reliable 30-point questionnaire that is used extensively in clinical and research settings to measure cognitive impairment. It is commonly used as screening tool for dementia. It is also used to estimate the severity and progression of cognitive impairment and to follow the course of cognitive changes in an individual over time; thus, making it an effective way to document an individual's response to treatment. The range is 0-30 with higher scores indicating better cognitive functioning.",
                    "populationDescription": "26 of the 27 participants completed the 12 month interval",
                    "reportingStatus": "POSTED",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "Spearman Rho",
                    "timeFrame": "Baseline to 12 months",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "All Subjects",
                            "description": "All subjects will complete PET imaging sessions evaluating the tau PET radioligand \\[18F\\]MK-6240 at baseline, as well as at 6, 12 and 24 months post-baseline.\n\nIf unable to complete the 6 month, 12 month, or 24 month visit, an 18 month and/or 30 month visit may instead be scheduled, totaling a maximum of four time points.\n\nAll Subjects: All subjects will be given the experimental tau PET radioligand \\[18F\\]MK-6240"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "27"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": ".43"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in [18F]MK-6240 Standard Uptake Value Ratio (SUVR) Uptake",
                    "description": "Composite mean SUVR across standard regions including: numerator was the entorhinal, amygdala, fusiform, inferior temporal, middle temporal cortex; denominator was the inferior cerebellum cortex. The SUVR is a ratio and has a theoretic interpretable minimum of 1.0. This primary outcome is reported by the three primary groups: Healthy Volunteers, Mild Cognitive Impairment, and Dementia.",
                    "populationDescription": "26 of the 27 participants completed the 24 month interval",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "SUVR",
                    "timeFrame": "Baseline to 24 months",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Healthy Volunteers",
                            "description": "As described in the study eligibility criteria:\n\n* Normal Cognition based on cognitive results at screening.\n* Healthy with no clinically relevant finding on physical examination at screening and upon reporting for the Baseline \\[18F\\]MK-6240 imaging visit.\n* CDR global score =0"
                        },
                        {
                            "id": "OG001",
                            "title": "Mild Cognitive Impairment",
                            "description": "As described in the study eligibility criteria:\n\n* Have screening \\[11C\\]PiB PET imaging demonstrating amyloid binding based on qualitative read or DVR index value \\>1.20.\n* MMSE score 26-30 (inclusive), CDR global score 0.5 for subjects with MCI\n* MMSE score 22-26 (inclusive), CDR global score 0.5 or 1 for subjects with mild dementia due to AD\n* MMSE score 16-21 (inclusive), CDR global score 1-2 for subjects with moderate dementia due to AD\n* A structural brain MRI with no evidence of non-AD disease to account for dementia or MRI exclusion criteria."
                        },
                        {
                            "id": "OG002",
                            "title": "Dementia",
                            "description": "As described in the study eligibility criteria:\n\n* Have screening \\[11C\\]PiB PET imaging demonstrating amyloid binding based on qualitative read or DVR index value \\>1.20.\n* MMSE score 26-30 (inclusive), CDR global score 0.5 for subjects with MCI\n* MMSE score 22-26 (inclusive), CDR global score 0.5 or 1 for subjects with mild dementia due to AD\n* MMSE score 16-21 (inclusive), CDR global score 1-2 for subjects with moderate dementia due to AD"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "6"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "8"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "13"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-.01",
                                            "spread": ".09"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": ".21",
                                            "spread": ".16"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": ".24",
                                            "spread": ".34"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "type": "SECONDARY",
                    "title": "Change in [18F]MK-6240 Standard Uptake Value Ratio (SUVR) Uptake",
                    "description": "Composite mean SUVR across standard regions including: numerator was the entorhinal, amygdala, fusiform, inferior temporal, middle temporal cortex; denominator was the inferior cerebellum cortex. The SUVR is a ratio and has a theoretic interpretable minimum of 1.0. This primary outcome is reported by the three primary groups: Healthy Volunteers, Mild Cognitive Impairment, and Dementia.",
                    "populationDescription": "26 of the 27 participants completed the 6 month interval",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "SUVR",
                    "timeFrame": "Baseline to 6 months",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Healthy Volunteers",
                            "description": "As described in the study eligibility criteria:\n\n* Normal Cognition based on cognitive results at screening.\n* Healthy with no clinically relevant finding on physical examination at screening and upon reporting for the Baseline \\[18F\\]MK-6240 imaging visit.\n* CDR global score =0"
                        },
                        {
                            "id": "OG001",
                            "title": "Mild Cognitive Impairment",
                            "description": "As described in the study eligibility criteria:\n\n* Have screening \\[11C\\]PiB PET imaging demonstrating amyloid binding based on qualitative read or DVR index value \\>1.20.\n* MMSE score 26-30 (inclusive), CDR global score 0.5 for subjects with MCI\n* MMSE score 22-26 (inclusive), CDR global score 0.5 or 1 for subjects with mild dementia due to AD\n* MMSE score 16-21 (inclusive), CDR global score 1-2 for subjects with moderate dementia due to AD\n* A structural brain MRI with no evidence of non-AD disease to account for dementia or MRI exclusion criteria."
                        },
                        {
                            "id": "OG002",
                            "title": "Dementia",
                            "description": "As described in the study eligibility criteria:\n\n* Have screening \\[11C\\]PiB PET imaging demonstrating amyloid binding based on qualitative read or DVR index value \\>1.20.\n* MMSE score 26-30 (inclusive), CDR global score 0.5 for subjects with MCI\n* MMSE score 22-26 (inclusive), CDR global score 0.5 or 1 for subjects with mild dementia due to AD\n* MMSE score 16-21 (inclusive), CDR global score 1-2 for subjects with moderate dementia due to AD"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "6"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "8"
                                },
                                {
                                    "groupId": "OG002",
                                    "value": "13"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "-.03",
                                            "spread": ".04"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "-.07",
                                            "spread": ".26"
                                        },
                                        {
                                            "groupId": "OG002",
                                            "value": ".19",
                                            "spread": ".33"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "0",
            "timeFrame": "Given that this longitudinal study involves procedures that will occur at 6-12 month intervals and does not include chronic treatment with an investigational agent, adverse events (AEs) and serious adverse events (SAEs) were captured during the study visit before and after PiB and MK6240 scans, within 24 hours after the scan. Adverse events were monitored from signing the informed consent form through study completion, on average 2.5 years.",
            "description": "The subjects received a phone call within 4 days from the study team for the purpose of ascertaining their wellbeing and information on adverse events that occur within 24 hours after the scan. If any adverse events were discovered, a clinician continued to follow up with the subject until resolved.",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "Dementia",
                    "description": "All subjects will complete PET imaging sessions evaluating the tau PET radioligand \\[18F\\]MK-6240 at baseline, as well as at 6, 12 and 24 months post-baseline.\n\nIf unable to complete the 6 month, 12 month, or 24 month visit, an 18 month and/or 30 month visit may instead be scheduled, totaling a maximum of four time points.\n\nAll Subjects: All subjects will be given the experimental tau PET radioligand \\[18F\\]MK-6240",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 13,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 13,
                    "otherNumAffected": 3,
                    "otherNumAtRisk": 13
                },
                {
                    "id": "EG001",
                    "title": "Healthy Volunteer",
                    "description": "All subjects will complete PET imaging sessions evaluating the tau PET radioligand \\[18F\\]MK-6240 at baseline, as well as at 6, 12 and 24 months post-baseline.\n\nIf unable to complete the 6 month, 12 month, or 24 month visit, an 18 month and/or 30 month visit may instead be scheduled, totaling a maximum of four time points.\n\nAll Subjects: All subjects will be given the experimental tau PET radioligand \\[18F\\]MK-6240",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 6,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 6,
                    "otherNumAffected": 1,
                    "otherNumAtRisk": 6
                },
                {
                    "id": "EG002",
                    "title": "Mild Cognitive Impairment",
                    "description": "All subjects will complete PET imaging sessions evaluating the tau PET radioligand \\[18F\\]MK-6240 at baseline, as well as at 6, 12 and 24 months post-baseline.\n\nIf unable to complete the 6 month, 12 month, or 24 month visit, an 18 month and/or 30 month visit may instead be scheduled, totaling a maximum of four time points.\n\nAll Subjects: All subjects will be given the experimental tau PET radioligand \\[18F\\]MK-6240",
                    "deathsNumAffected": 0,
                    "deathsNumAtRisk": 8,
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 8,
                    "otherNumAffected": 0,
                    "otherNumAtRisk": 8
                }
            ],
            "otherEvents": [
                {
                    "term": "Injection Site Reaction",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "CTCAE (Unspecified)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 13
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 6
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 8
                        }
                    ]
                },
                {
                    "term": "Back Pain",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "sourceVocabulary": "CTCAE (Unspecified)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 13
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 6
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 8
                        }
                    ]
                },
                {
                    "term": "Infusion Site Extravasation",
                    "organSystem": "General disorders",
                    "sourceVocabulary": "CTCAE (Unspecified)",
                    "assessmentType": "SYSTEMATIC_ASSESSMENT",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 13
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 6
                        },
                        {
                            "groupId": "EG002",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 8
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "limitationsAndCaveats": {
                "description": "This study included a small sample size of 6 healthy volunteers, 8 Mild Cognitive Impairment, and 13 Dementia subjects. This limits the statistical conclusions of the study. The study subjects were all non-hispanic, white participants. This limits the generalizability of the results."
            },
            "certainAgreement": {
                "piSponsorEmployee": false,
                "restrictiveAgreement": false
            },
            "pointOfContact": {
                "title": "Dr. Sterling Johnson",
                "organization": "University of WI Alzheimer's Disease Research Center",
                "email": "scj@medicine.wisc.edu",
                "phone": "608-262-9549"
            }
        }
    },
    "target_category": "N/A",
    "drug": [
        "[18F]MK-6240 (tau PET radioligand)",
        "[11C]PiB (amyloid PET radioligand)"
    ],
    "placebo": [],
    "explanation_target": [
        "Reason: The protocol describes a longitudinal, observational imaging study of the PET radioligand [18F]MK-6240 to characterize tau imaging in AD/MCI/healthy volunteers. [18F]MK-6240 is a diagnostic PET tracer selective for neurofibrillary tangles (tau), not a therapeutic agent. \ue200cite\ue202turn0search3\ue202turn0search2\ue202turn0search0\ue201",
        "Act: Extracted details \u2014 interventions and procedures are imaging agents ([18F]MK-6240 for tau PET, [11C]PiB for amyloid PET) plus structural MRI, with serial scans at baseline and follow-up timepoints. These are biomarker/imaging tools used for diagnosis/monitoring, not drugs intended to modify disease, improve cognition, or treat neuropsychiatric symptoms. \ue200cite\ue202turn0search2\ue202turn0search0\ue202turn0search4\ue201",
        "Reflect: Classification = 'N/A' because the study evaluates diagnostic PET radiotracers (biomarkers). It does not test a therapeutic biologic or small molecule targeting pathology for disease modification, nor a cognitive enhancer or symptom-management intervention. MK-6240 binds tau (NFTs) and is used as an imaging biomarker; PiB binds fibrillar amyloid \u2014 both consistent with diagnostic use. \ue200cite\ue202turn0search2\ue202turn0search4\ue202turn0search1\ue201",
        "Web search results consulted: (1) J. Med. Chem. discovery/description of [18F]-MK-6240 as a PET tracer for neurofibrillary tangles. \ue200cite\ue202turn0search2\ue201",
        "(2) PubMed article on radiosynthesis and characterization of [18F]MK-6240. \ue200cite\ue202turn0search0\ue201",
        "(3) First-in-human/dosimetry and characterization reports (Alzheimer's & Dementia conference abstract). \ue200cite\ue202turn0search3\ue201",
        "(4) Recent PubMed article reviewing MK-6240 tau-PET specificity for AD tauopathy. \ue200cite\ue202turn0search1\ue201",
        "(5) Background literature on [11C]PiB as an amyloid PET tracer. \ue200cite\ue202turn0search4\ue201"
    ],
    "agent_type": "N/A",
    "explanation_agent": []
}